Structure and immunogenicity of alternative forms of the simian immunodeficiency virus gag protein expressed using Venezuelan equine encephalitis virus replicon particles-Reference-Cited by-同舟云学术

Structure and immunogenicity of alternative forms of the simian immunodeficiency virus gag protein expressed using Venezuelan equine encephalitis virus replicon particles

Published:2007-06 Issue:2 Volume:362 Page:362-373
ISSN:0042-6822
Container-title:Virology
language:en
Short-container-title:Virology

Author:

Cecil Chad,West Ande,Collier Martha,Jurgens Christy,Madden Victoria,Whitmore Alan,Johnston Robert,Moore Dominic T.,Swanstrom Ronald,Davis Nancy L.

Publisher

Elsevier BV

Subject

Virology

Reference59 articles.

1. A new generation of HIV vaccines;Amara;Trends Mol. Med.,2002

2. Multiple extracellular elements of CCR5 and HIV-1 entry: dissociation from response to chemokines;Atchison;Science,1996

3. Expression of the two major envelope proteins of equine arteritis virus as a heterodimer is necessary for induction of neutralizing antibodies in mice immunized with recombinant Venezuelan equine encephalitis virus replicon particles;Balasuriya;J. Virol.,2000

4. Elicitation of high-frequency cytotoxic T-lymphocyte responses against both dominant and subdominant simian–human immunodeficiency virus epitopes by DNA vaccination of rhesus monkeys;Barouch;J. Virol.,2001

5. Cytotoxic T cells from human immunodeficiency virus type 2-infected patients frequently cross-react with different human immunodeficiency virus type 1 clades;Bertoletti;J. Virol.,1998

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Novel Self-Replicating Chimeric Lentivirus-Like Particle;Journal of Virology;2011-10-19

2. Recombinant Vectors as Influenza Vaccines;Current Topics in Microbiology and Immunology;2009

3. Kunjin replicon-based simian immunodeficiency virus gag vaccines;Vaccine;2008-06

4. Effects of rapid antigen degradation and VEE glycoprotein specificity on immune responses induced by a VEE replicon vaccine;Virology;2008-01